APC and prostate cancer: Genetic analysis studies have found APC mutations in 4% of patients with locoregional prostate cancer, that APC alterations were enriched in metastatic (15%) versus locoregional disease, and that 24% of patients with ductal carcinoma of the prostate had APC mutations [7, 8].